Real ChatGPT answer · index seednsqVbiK8egccompleteHealth and wellness · women's healthinformational
I am entering perimenopause and considering starting hormone replacement therapy, but I want to know what the current medical guidelines say about long-term breast cancer risks before I talk to my doctor.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
I am entering perimenopause and considering starting hormone replacement therapy, but I want to know what the current medical guidelines say about long-term breast cancer risks before I talk to my doctor.
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
2026 menopause hormone therapy breast cancer risk guideline official NAMS ACOG NICE position statement Google ↗
2026 menopause hormone therapy breast cancer risk guidelines NAMS ACOG NICE combined estrogen progestogen duration absolute risk Google ↗
- Recommendations | Menopause: identification and management | Guidance · nice.org.uk
- Full article: International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause · doi.org
- NG23 Menopause: Evidence review D: Breast cancer 07/11/2024 · ncbi.nlm.nih.gov
- Menopausal Hormone Therapy and Cancer · cancer.gov
- Hormone therapy safety · womenshealth.gov
- Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping · gov.uk
- HRT and BC risk in those with a Family History v1.0 19/01/2025 · associationofbreastsurgery.org.uk
- What to Know About Hormone Replacement Therapy (HRT) and Cancer Risk · cancer.org
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 menopause hormone therapy breast cancer risk guideline official NAMS ACOG NICE position statement OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
2026 menopause hormone therapy breast cancer risk guidelines NAMS ACOG NICE combined estrogen progestogen duration absolute risk OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |